190 related articles for article (PubMed ID: 17073438)
1. Importance of Ca(2+)-dependent transamidation activity in the protection afforded by tissue transglutaminase against doxorubicin-induced apoptosis.
Datta S; Antonyak MA; Cerione RA
Biochemistry; 2006 Nov; 45(44):13163-74. PubMed ID: 17073438
[TBL] [Abstract][Full Text] [Related]
2. GTP-binding-defective forms of tissue transglutaminase trigger cell death.
Datta S; Antonyak MA; Cerione RA
Biochemistry; 2007 Dec; 46(51):14819-29. PubMed ID: 18052077
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells.
Antonyak MA; Miller AM; Jansen JM; Boehm JE; Balkman CE; Wakshlag JJ; Page RL; Cerione RA
J Biol Chem; 2004 Oct; 279(40):41461-7. PubMed ID: 15272014
[TBL] [Abstract][Full Text] [Related]
4. GTP is required to stabilize and display transamidation activity of transglutaminase 2.
Jeon JH; Cho SY; Kim CW; Shin DM; Kweon JC; Choi KH; Park SC; Kim IG
Biochem Biophys Res Commun; 2002 Jun; 294(4):818-22. PubMed ID: 12061780
[TBL] [Abstract][Full Text] [Related]
5. The core domain of the tissue transglutaminase Gh hydrolyzes GTP and ATP.
Iismaa SE; Chung L; Wu MJ; Teller DC; Yee VC; Graham RM
Biochemistry; 1997 Sep; 36(39):11655-64. PubMed ID: 9305955
[TBL] [Abstract][Full Text] [Related]
6. Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis.
Antonyak MA; Singh US; Lee DA; Boehm JE; Combs C; Zgola MM; Page RL; Cerione RA
J Biol Chem; 2001 Sep; 276(36):33582-7. PubMed ID: 11438548
[TBL] [Abstract][Full Text] [Related]
7. Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb.
Boehm JE; Singh U; Combs C; Antonyak MA; Cerione RA
J Biol Chem; 2002 Jun; 277(23):20127-30. PubMed ID: 11956182
[TBL] [Abstract][Full Text] [Related]
8. GTP binding and signaling by Gh/transglutaminase II involves distinct residues in a unique GTP-binding pocket.
Iismaa SE; Wu MJ; Nanda N; Church WB; Graham RM
J Biol Chem; 2000 Jun; 275(24):18259-65. PubMed ID: 10747935
[TBL] [Abstract][Full Text] [Related]
9. Phospholipase C, Ca2+, and calmodulin signaling are required for 5-HT2A receptor-mediated transamidation of Rac1 by transglutaminase.
Dai Y; Dudek NL; Li Q; Muma NA
Psychopharmacology (Berl); 2011 Feb; 213(2-3):403-12. PubMed ID: 20717650
[TBL] [Abstract][Full Text] [Related]
10. Two isoforms of tissue transglutaminase mediate opposing cellular fates.
Antonyak MA; Jansen JM; Miller AM; Ly TK; Endo M; Cerione RA
Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18609-14. PubMed ID: 17116873
[TBL] [Abstract][Full Text] [Related]
11. High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells.
Mehta K
Int J Cancer; 1994 Aug; 58(3):400-6. PubMed ID: 7914183
[TBL] [Abstract][Full Text] [Related]
12. Expression and activity of transglutaminase II in spontaneous tumours of dogs and cats.
Wakshlag JJ; McNeill CJ; Antonyak MA; Boehm JE; Fuji R; Balkman CE; Zgola M; Cerione RA; Page RL
J Comp Pathol; 2006; 134(2-3):202-10. PubMed ID: 16615935
[TBL] [Abstract][Full Text] [Related]
13. Transglutaminase-catalyzed transamidation: a novel mechanism for Rac1 activation by 5-hydroxytryptamine2A receptor stimulation.
Dai Y; Dudek NL; Patel TB; Muma NA
J Pharmacol Exp Ther; 2008 Jul; 326(1):153-62. PubMed ID: 18400843
[TBL] [Abstract][Full Text] [Related]
14. Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient.
Bernassola F; Federici M; Corazzari M; Terrinoni A; Hribal ML; De Laurenzi V; Ranalli M; Massa O; Sesti G; McLean WH; Citro G; Barbetti F; Melino G
FASEB J; 2002 Sep; 16(11):1371-8. PubMed ID: 12205028
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for the coordinated regulation of transglutaminase 3 by guanine nucleotides and calcium/magnesium.
Ahvazi B; Boeshans KM; Idler W; Baxa U; Steinert PM; Rastinejad F
J Biol Chem; 2004 Feb; 279(8):7180-92. PubMed ID: 14645372
[TBL] [Abstract][Full Text] [Related]
16. Ca2+: a stabilizing component of the transglutaminase activity of Galphah (transglutaminase II).
Lee SC; Kim JH; Park ES; Kim DK; Kim YG; Yun HY; Kwon NS; Im MJ; Baek KJ
Mol Cells; 2003 Dec; 16(3):285-90. PubMed ID: 14744016
[TBL] [Abstract][Full Text] [Related]
17. Osmotic resistance of high-density erythrocytes in transglutaminase 2-deficient mice.
Bernassola F; Boumis G; Corazzari M; Bertini G; Citro G; Knight RA; Amiconi G; Melino G
Biochem Biophys Res Commun; 2002 Mar; 291(5):1123-7. PubMed ID: 11883932
[TBL] [Abstract][Full Text] [Related]
18. Renal cell carcinoma escapes death by p53 depletion through transglutaminase 2-chaperoned autophagy.
Kang JH; Lee JS; Hong D; Lee SH; Kim N; Lee WK; Sung TW; Gong YD; Kim SY
Cell Death Dis; 2016 Mar; 7(3):e2163. PubMed ID: 27031960
[TBL] [Abstract][Full Text] [Related]
19. Identification of the eukaryotic initiation factor 5A as a retinoic acid-stimulated cellular binding partner for tissue transglutaminase II.
Singh US; Li Q; Cerione R
J Biol Chem; 1998 Jan; 273(4):1946-50. PubMed ID: 9442029
[TBL] [Abstract][Full Text] [Related]
20. Effects of tissue transglutaminase on beta -amyloid1-42-induced apoptosis.
Wakshlag JJ; Antonyak MA; Boehm JE; Boehm K; Cerione RA
Protein J; 2006 Jan; 25(1):83-94. PubMed ID: 16721663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
